Pallas Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,585	Closed	-$2.53M	–	607
2024 Q2	$2.53M	Buy	11,585 +647	+6%	+$147K	0.11%	135
2024 Q1	$2.96M	Buy	10,938 +5,295	+94%	+$1.26M	0.12%	131
2023 Q4	$1.33M	Sell	5,643 -4,441	-44%	-$873K	0.07%	175
2023 Q3	$1.66M	Buy	10,084 +415	+4%	+$85.2K	0.1%	151
2023 Q2	$2.02M	Buy	9,669 +2,016	+26%	+$401K	0.09%	125
2023 Q1	$1.56M	Buy	7,653 +421	+6%	+$95.4K	0.15%	106
2022 Q4	$1.76M	Sell	7,232 -57	-0.8%	-$12.4K	0.18%	99
2022 Q3	$1.58M	Buy	7,289 +672	+10%	+$145K	0.18%	97
2022 Q2	$1.57M	Buy	+6,617	New	+$1.62M	0.22%	82
2021 Q4	–	Sell	-729	Closed	-$283K	–	357
2021 Q3	$283K	Sell	729 -227	-24%	-$94.3K	0.03%	316
2021 Q2	$398K	Buy	+956	New	+$319K	0.06%	219